142 related articles for article (PubMed ID: 20881859)
1. Ovarian clear cell carcinoma with choriocarcinomatous differentiation: report of a rare and aggressive tumor.
Hu YJ; Ip PP; Chan KK; Tam KF; Ngan HY
Int J Gynecol Pathol; 2010 Nov; 29(6):539-45. PubMed ID: 20881859
[TBL] [Abstract][Full Text] [Related]
2. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease.
Ho CM; Huang YJ; Chen TC; Huang SH; Liu FS; Chang Chien CC; Yu MH; Mao TL; Wang TY; Hsieh CY
Gynecol Oncol; 2004 Jul; 94(1):197-203. PubMed ID: 15262142
[TBL] [Abstract][Full Text] [Related]
3. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
4. Rectal adenocarcinoma with choriocarcinomatous differentiation: clinical and genetic aspects.
Verbeek W; Schulten HJ; Sperling M; Tiesmeier J; Stoop H; Dinjens W; Looijenga L; Wörmann B; Füzesi L; Donhuijsen K
Hum Pathol; 2004 Nov; 35(11):1427-30. PubMed ID: 15668903
[TBL] [Abstract][Full Text] [Related]
5. Concurrent ovarian-type primary peritoneal adenocarcinoma and peritoneal choriocarcinoma. A case report and review of the literature.
Pentheroudakis G; White J; Davis J; Brown I; Vasey P
Gynecol Oncol; 2004 Feb; 92(2):697-700. PubMed ID: 14766269
[TBL] [Abstract][Full Text] [Related]
6. Ovarian nongestational choriocarcinoma mixed with various epithelial malignancies in association with endometriosis.
Hirabayashi K; Yasuda M; Osamura RY; Hirasawa T; Murakami M
Gynecol Oncol; 2006 Jul; 102(1):111-7. PubMed ID: 16527336
[TBL] [Abstract][Full Text] [Related]
7. Mixed ovarian large cell neuroendocrine carcinoma, mucinous adenocarcinoma, and teratoma: a report of two cases and review of the literature.
Chênevert J; Bessette P; Plante M; Têtu B; Dubé V
Pathol Res Pract; 2009; 205(9):657-61. PubMed ID: 19577382
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S
Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
10. Ovarian large cell neuroendocrine carcinoma.
Tsuji T; Togami S; Shintomo N; Fukamachi N; Douchi T; Taguchi S
J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):726-30. PubMed ID: 18840191
[TBL] [Abstract][Full Text] [Related]
11. [A case of clear cell carcinoma of the ovary responding to a paclitaxel-carboplatin combination chemotherapy].
Fujiwara K; Maehata K; Kohno I; Yoden E; Imajo Y; Mikami Y
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2259-62. PubMed ID: 11142173
[TBL] [Abstract][Full Text] [Related]
12. Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy.
Bamias A; Psaltopoulou T; Sotiropoulou M; Haidopoulos D; Lianos E; Bournakis E; Papadimitriou C; Rodolakis A; Vlahos G; Dimopoulos MA
Cancer; 2010 Mar; 116(6):1462-8. PubMed ID: 20108307
[TBL] [Abstract][Full Text] [Related]
13. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
Wu LY; Zhang R; Huang MN; Li N; Wang GX; Liu LY
Ai Zheng; 2003 Apr; 22(4):424-7. PubMed ID: 12704005
[TBL] [Abstract][Full Text] [Related]
14. Malignant ovarian tumor composed of endometrioid adenocarcinoma, clear cell adenocarcinoma, squamous cell carcinoma, yolk sac tumor and immature teratoma with prominent neuroectodermal and rhabdomyosarcomatous differentiation: a case study.
Ohishi Y; Kaku T; Kaneki E; Wake N; Tsuneyoshi M
Gynecol Oncol; 2007 May; 105(2):548-52. PubMed ID: 17341430
[TBL] [Abstract][Full Text] [Related]
15. The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study.
Chan JK; Tian C; Fleming GF; Monk BJ; Herzog TJ; Kapp DS; Bell J
Gynecol Oncol; 2010 Mar; 116(3):301-6. PubMed ID: 19945740
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma erysipeloides from ovarian clear-cell carcinoma.
Lee HC; Chu CY; Hsiao CH
J Clin Oncol; 2007 Dec; 25(36):5828-30. PubMed ID: 18089882
[No Abstract] [Full Text] [Related]
17. Gynecological malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1996; 16():564-91. PubMed ID: 8639401
[TBL] [Abstract][Full Text] [Related]
18. Ovarian nongestational choriocarcinoma and associated adenocarcinoma with the same germ cell origin determined by a molecular genetic approach: A case report.
Koyanagi T; Fujiwara H; Usui H; Ariga H; Machida S; Takei Y; Saga Y; Shozu M; Fukushima N; Niki T; Matsubara S; Suzuki M
Pathol Int; 2016 Sep; 66(9):529-34. PubMed ID: 27484620
[TBL] [Abstract][Full Text] [Related]
19. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.
Han G; Gilks CB; Leung S; Ewanowich CA; Irving JA; Longacre TA; Soslow RA
Am J Surg Pathol; 2008 Jul; 32(7):955-64. PubMed ID: 18460981
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of postoperative morbidities in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy and delayed primary surgical debulking.
Le T; Alshaikh G; Hopkins L; Faught W; Fung MF
Ann Surg Oncol; 2006 Dec; 13(12):1711-6. PubMed ID: 17009146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
